Edition:
United States

Nuvectra Corp (NVTR.OQ)

NVTR.OQ on NASDAQ Stock Exchange Global Market

16.10USD
16 Jul 2018
Change (% chg)

-- (--)
Prev Close
$16.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
59,733
52-wk High
$23.64
52-wk Low
$7.65

Latest Key Developments (Source: Significant Developments)

Nuvectra Provides Update On FDA And TÜV SÜD Review Of Virtis™ PMA And CE Mark Applications
Monday, 2 Jul 2018 07:30am EDT 

July 2 (Reuters) - Nuvectra Corp ::NUVECTRA PROVIDES UPDATE ON FDA AND TÜV SÜD REVIEW OF VIRTIS™ PMA AND CE MARK APPLICATIONS.NUVECTRA - FDA RECENTLY REQUESTED TO PROVIDE SUPPLEMENTAL INFORMATION RELATED TO CHANGES TO VIRTIS DEVICE, LABELING AND MANUFACTURING.NUVECTRA - FDA ALSO RECENTLY REQUESTED TO PROVIDE CLARIFICATIONS OF DATA RELATED TO MRI.NUVECTRA CORP - HAS BEEN IN ACTIVE COMMUNICATIONS WITH FDA AND INTENDS TO FILE COMPREHENSIVE RESPONSES TO ADDRESS FDA'S REQUESTS.NUVECTRA CORP - TÜV SÜD RECENTLY INFORMED CO CLINICAL STUDY DATA WILL BE REQUIRED BEFORE IT CAN RECOMMEND APPROVAL OF CE MARK FOR VIRTIS SYSTEM.  Full Article

Nuvectra Q4 Loss Per Share $0.80
Tuesday, 6 Mar 2018 04:01pm EST 

March 6 (Reuters) - Nuvectra Corp ::NUVECTRA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.80.Q4 REVENUE ROSE 188 PERCENT TO $12 MILLION.  Full Article

Nuvectra Says Public Offering Of 2.83 Mln Shares Priced At $8 Per Share
Thursday, 1 Feb 2018 09:00am EST 

Feb 1 (Reuters) - Nuvectra Corp ::NUVECTRA™ ANNOUNCES PRICING OF FOLLOW-ON STOCK OFFERING.SAYS PUBLIC OFFERING OF 2.83 MILLION COMMON SHARES PRICED AT $8.00PER SHARE.  Full Article

Nuvectra Sees Q4 Revenue $11.5 Mln To $12 Mln
Monday, 8 Jan 2018 08:00am EST 

Jan 8 (Reuters) - Nuvectra Corp ::NUVECTRA ANNOUNCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2017 REVENUE.SEES Q4 REVENUE $11.5 MILLION TO $12 MILLION.SEES FY 2017 REVENUE $31.5 MILLION TO $32 MILLION.  Full Article

Nuvectra reports Q3 loss per share $1.09
Wednesday, 1 Nov 2017 04:01pm EDT 

Nov 1 (Reuters) - Nuvectra Corp :Nuvectra reports third quarter 2017 financial results.Q3 loss per share $1.09.Q3 revenue rose 102 percent to $7.6 million.  Full Article

Nuvectra corp files for mixed shelf of upto $100 mln
Thursday, 5 Oct 2017 02:16pm EDT 

Oct 5 (Reuters) - Nuvectra Corp :Nuvectra Corp files for mixed shelf of upto $100 million - sec filing‍​.  Full Article

Nuvectra corp says effective Aug. 31, co entered into amended and restated development agreement with Aleva Neurotherapeutics - SEC filing
Tuesday, 5 Sep 2017 09:47am EDT 

Sept 5 (Reuters) - Nuvectra Corp :Nuvectra Corp - effective august 31, co entered into amended and restated development agreement with Aleva Neurotherapeutics, S.A - SEC filing.Nuvectra corp - agreement amends and restates terms of development agreement between Aleva and Nuvectra, dated January 29, 2016.Nuvectra Corp-Aleva and Nuvectra agree to collaborate on development of deep brain stimulation product that may be used to treat Parkinson's disease.Nuvectra Corp - Aleva will pay nuvectra monthly for all services it provides on a time and material basis, as invoiced by Nuvectra.  Full Article

Nuvectra Q2 loss per share $1.07
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 8 (Reuters) - Nuvectra Corp :Nuvectra reports second quarter 2017 financial results.Q2 loss per share $1.07.Q2 revenue rose 183 percent to $7.2 million.  Full Article

Nuvectra unit enters into business property lease agreement
Friday, 30 Jun 2017 04:57pm EDT 

June 30 (Reuters) - Nuvectra Corp ::Nuvectra Corp - effective July 1, 2017, unit entered into a business property lease agreement with BMT Ann Arbor, Llc.  Full Article

Nuvectra enters second amendment to development agreement with Aleva Neurotherapeutics
Wednesday, 21 Jun 2017 05:17pm EDT 

June 21 (Reuters) - Nuvectra Corp -:Nuvectra- effective june 19, co entered second amendment to development agreement with aleva neurotherapeutics, s.a to amend agreement dated jan 29, 2016.Nuvectra-Under terms, aleva, co to modify payment schedule, timing of certain payments, any additional work performed by co to be paid on monthly basis.  Full Article

BRIEF-Nuvectra Q4 Loss Per Share $0.80

* NUVECTRA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS